The Prime Minister interacted with top scientists at Serum Institute of India and sought to know the status of the trials
Dr Cyrus Poonawalla welcomed the Prime Minister along with his son and SII CEO Adar and the latter’s wife, Natasha.
Prime Minister Narendra Modi, who carried out a three-city visit to “understand the process of vaccine production and distribution” on Saturday, spent an hour at the Serum Institute of India (SII) in Pune, the last of his three stops.
Serum Institute of India has partnered with AstraZeneca and University of Oxford to manufacture the Covishield vaccine.
“It was an excellent visit. The Prime Minister was highly impressed with the manufacturing facility at Serum Institute and asked us to come out with the vaccine at the earliest,” 79-year-old Dr Cyrus Poonawalla, chairman of the Poonawalla Group, told The Indian Express
Dr Cyrus Poonawalla, his son Adar, the CEO of Serum Institute of India, and his daughter-in-law Natasha welcomed the Prime Minister to the institute. Modi interacted with the scientists at Serum Institute and visited the vaccine manufacturing facility at Manjari.
“While the Prime Minister lauded the efforts to come out with the vaccine as soon as possible, he spent one hour at the facility, understanding in great detail what we are doing and how we are taking things forward. He told us to employ someone intelligent to educate the people… that they must take the vaccine… otherwise, there may be reluctance in some ignorant population who are not aware of the advantages,” said Dr Poonawalla.
The Prime Minister interacted with top scientists at the Serum Institute of India, to better understand how the scale-up is done and what the production capacity is. He also asked questions on the status of the trial. “He asked us if the government can help in the effort,” said Dr Poonawalla.
Dr Rajeev Dhere, executive director at the Serum Institute of India, said the Prime Minister was very simple and asked to-the-point questions. “It was a very positive experience,” Dr Dhere told The Indian Express.
Earlier, Modi was received at the Pune airport by Southern Army Commander Lieutenant General C P Mohanty, Air Commodore H Assudani, Director General of Maharashtra Police Subodh Jaiswal, Divisional Commissioner Saurabh Rao, City Police Commissioner Amitabh Gupta and District Collector Dr Rajesh Deshmukh.
Source - Indian Express
Serum Institute Of India sends out Covishield vaccine - Consignment of Covishield Vaccine arrived in Delhi, Chennai, Kolkata, Guwahati, Shillong, Ahmedabad, Hydrabad, Vijayawada, Bhubaneswar, Patna, Bengaluru, Lucknow, Chandigarh
Serum Institute of India launches India’s first fully indigenously developed pneumococcal vaccine, 'PNEUMOSIL'
Oxford COVID-19 vaccine: Serum Institute likely to submit final Covishield trial data within 10 days
SII’s Adar Poonawalla on Covid vaccine, pricing and rollout at Hindustan Times Leadership Summit 2020
COVISHIELD Completes Enrolment of Phase III clinical trials under partnership of ICMR and Serum Institute of India
Government Secures Vaccine Supplies For Half Of The Indian Population From Serum Institute And Novavax
IAVI, Merck, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access
Serum Institute Of India Takes A Multipronged Approach In Quest To Produce World’s First Covid-19 Vaccines
Serum Institute of India to produce up to an additional 100 million covid 19 vaccine doses for india and low and midle income countries in 2021
Adar Poonawalla CEO of Serum Institute of India, the world’s largest vaccine manufacturer, explains the timing, challenges & cost of vaccinating the world against COVID-19
Serum Institute looking for a $1 billion shot to fight covid, talks on with Blackstone, KKR and others
Serum Institute of India Says Covid Vaccine Likely to Be Ready by End of 2020, Final Pricing in 2 Months
Serum institute of india to produce up to 100 million covid-19 vaccine doses for india and low-and middle-income countries as early as 2021
50% of our Covid vaccines will be for India, people won't have to buy them, govts will pay: Adar Poonawalla
AstraZeneca vaccine's success in early human trials, Will Begin AstraZeneca Vaccine Trial in India After Applying for Licence Next Week, Says Serum Institute
Serum Institute of India CEO: ‘We plan to make millions of doses of Covid vaccine over three months’:’
New supply agreement between UNICEF and Serum Institute of India makes pneumococcal conjugate vaccine available at US$2.00 per dose, a 43 % reduction from the Gavi price at the start of the Advance Market Commitment
Serum Institute confident of manufacturing Covid vaccine’s 100 million doses if trials establish efficacy
Serum Institute’s Journey To Success | ET NOW Covid-19 vaccine possible by Q2 of 2022: Adar Poonawalla
Adar Poonawalla discusses Serum Institute's progress in the global battle against COVID-19 with Shereen Bhan, CNBC-TV18
Adar Poonawalla talks with Aabha Bakaya about the success story of Serum Institute of India. Tune in to know all about the journey of the company.
Bill Gates confers Indian Council of Medical Research "Lifetime Achievement Medal" on Dr. Cyrus Poonawalla
Dr. Cyrus Poonawalla conferred with 'Lifetime Achievement Award’ by the Asian Business Leadership Forum
Dr. Cyrus Poonawalla conferred with the prestigious honorary degree by the University of Oxford, U.K.